RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 22, 16:00
RVL Pharmaceuticals Cash from Investing (Quarterly): -0.959M for June 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.959M |
| March 31, 2023 | -1.225M |
| December 31, 2022 | -0.172M |
| September 30, 2022 | 0.231M |
| June 30, 2022 | 0.057M |
| March 31, 2022 | 0.01M |
| December 31, 2021 | -0.075M |
| September 30, 2021 | 110.60M |
| June 30, 2021 | -0.954M |
| March 31, 2021 | 6.881M |
| December 31, 2020 | -0.712M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.692M |
| June 30, 2020 | -0.734M |
| March 31, 2020 | -0.946M |
| December 31, 2019 | -0.956M |
| September 30, 2019 | -0.973M |
| June 30, 2019 | -1.456M |
| March 31, 2019 | -0.635M |
| December 31, 2018 | -1.146M |
| September 30, 2018 | -0.8068M |
| June 30, 2018 | -0.7445M |
| March 31, 2018 | -1.437M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.456M
Minimum
Jun 2019
110.60M
Maximum
Sep 2021
6.349M
Average
-0.712M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.06M |
| Cash from Financing (Quarterly) | -0.46M |
| Free Cash Flow | -47.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1319 |
| Free Cash Flow to Equity (Quarterly) | -13.67M |
| Free Cash Flow to Firm (Quarterly) | -9.966M |